| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.42▼ | 2.40▲ | 2.39▲ | 2.40▲ | 2.36▲ |
| MA10 | 2.41▲ | 2.38▲ | 2.40▲ | 2.38▲ | 2.66▼ |
| MA20 | 2.39▲ | 2.39▲ | 2.39▲ | 2.34▲ | 2.72▼ |
| MA50 | 2.38▲ | 2.39▲ | 2.36▲ | 2.75▼ | 2.35▲ |
| MA100 | 2.39▲ | 2.36▲ | 2.36▲ | 2.72▼ | 2.27▲ |
| MA200 | 2.39▲ | 2.35▲ | 2.48▼ | 2.37▲ | 2.19▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.002▲ | 0.000▲ | 0.029▲ | -0.086▼ |
| RSI | 60.083▲ | 58.996▲ | 56.836▲ | 46.413▼ | 45.738▼ |
| STOCH | 74.074 | 66.807 | 55.934 | 64.275 | 17.954▼ |
| WILL %R | -33.333 | -21.053▲ | -21.053▲ | -28.333 | -78.333▼ |
| CCI | 64.615 | 97.259 | 77.778 | 37.883 | -86.194 |
|
Thursday, November 13, 2025 10:58 AM
Stereotaxis STXS recently secured FDA 510(k) clearance for GenesisX, its next-generation robotic system designed to make endovascular surgical robotics far more accessible. The approval marks a ...
|
|
Tuesday, November 11, 2025 02:10 PM
Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.08 per share a year ago. These figures ...
|
|
Tuesday, November 11, 2025 08:01 AM
ST. LOUIS, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/12/25 | 2.34 | 2.435 | 2.34 | 2.415 | 335,519 |
| 09/12/25 | 2.37 | 2.43 | 2.36 | 2.38 | 249,500 |
| 08/12/25 | 2.41 | 2.41 | 2.34 | 2.36 | 256,600 |
| 05/12/25 | 2.45 | 2.45 | 2.38 | 2.41 | 207,600 |
| 04/12/25 | 2.35 | 2.458 | 2.32 | 2.43 | 331,610 |
| 03/12/25 | 2.26 | 2.34 | 2.2298 | 2.33 | 620,639 |
| 02/12/25 | 2.35 | 2.36 | 2.21 | 2.25 | 540,000 |
| 01/12/25 | 2.44 | 2.45 | 2.33 | 2.34 | 361,000 |
| 28/11/25 | 2.42 | 2.46 | 2.40 | 2.46 | 187,954 |
| 26/11/25 | 2.48 | 2.48 | 2.40 | 2.43 | 373,600 |
|
|
||||
|
|
||||
|
|